Culture conditions shape mesenchymal stromal cell phenotype and function

Cytotherapy

Volumn 11, Issue 2, 2009, Pages 101-102

  Horwitz, Edwin M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL THERAPY; CRYOPRESERVATION; CULTURE TECHNIQUE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RESPONSE; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; NOTE; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; STROMA CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CRYOPRESERVATION; GRAFT VS HOST DISEASE; HUMANS; IMMUNITY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PHENOTYPE; RECOVERY OF FUNCTION; REGENERATIVE MEDICINE; SPINAL CORD INJURIES; STROMAL CELLS;

EID: 68049129278     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240902757064     Document Type: Note

References (9)

1. Horwitz E, Le BK, Dominici M, Mueller I, Slaper-Cortenbach I, Marini F et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7(5):393-5.
2. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-7.
3. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33(11):1402-16.
4. Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J et al. The heterogeneity of human mesenchymal stem cell preparations: evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 2006;34(4):536-48.
5. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 2008;10(8):771-4.
6. Samuelsson H, Ringdén O, Lönnies H & Le Blanc K. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy 2009;11:129-136.
7. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363(9419):1439-41.
8. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371(9624):1579-86.
9. Naghdi M, Tiraihi T, Mesbah Namin SA, Arabkheradmand J. Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: A potential source for cell therapy in spinal cord injury. Cytotherapy 2009;11:137-152.